Bactericidal activity of ramoplanin against antibiotic-resistant enterococci.

AUTOR(ES)

Johnson, C C

RESUMO

Ramoplanin, a new lipoglycodepsipeptide antibiotic, was uniformly active against 65 strains of enterococci, including strains highly resistant to vancomycin, penicillin G, and gentamicin. MBCs were usually within a fourfold dilution of the MICs. In time-kill studies, ramoplanin alone demonstrated dose-dependent bactericidal activity against enterococcal strains that resisted killing by vancomycin or penicillin in combination with gentamicin.

Documentos Relacionados

• Cefoxitin Activity Against Multiply Antibiotic-Resistant Klebsiella pneumoniae In Vitro
• Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli.
• Does prolonged exposure to antibiotic-resistant bacteria increase the rate of antibiotic-resistant infection?
• Antibiotic-resistant Staphylococcal Pseudomembraneous Enteritis
• Virulence of antibiotic-resistant Salmonella typhimurium